Mepha LLC merges with Acino Pharma
Swiss-based pharmaceutical company Mepha LLC has merged with another Swiss-headquartered company Acino Pharma Ltd. Post merger, Oculus Pharmacare Ltd, which is a representative of Mepha in Nigeria said, the name, Mepha LLC will no longer be used.
The newly formed merged company will now operate and be known as Acino Pharma Ltd. The merger will benefit patients, doctors, and other stakeholders of the industry because of their vision to develop high quality healthcare products.
Acino has expertise in advanced drug delivery technologies and also has a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release tablets.
Acino supplies finished in-house developed products. It also provides customized one-stop solutions from product development and registration to contract manufacturing, and packaging and logistics.
It also markets Swiss-quality medicines all over the globe.
The management of the newly formed merged company said, “Because of Acino’s special know-how in advanced and refined drug delivery, we will not only provide the highest quality healthcare for patients and stakeholders, but will also serve customers with great passion as well as bring effective and value-added drugs to enhance the quality of life.”
Mepha LLC develops, produces and markets beneficial, well-tolerate and high-value medicines. It also develops and produces products in Switzerland using highest, Swiss-quality standards.
